Valisure President David Light recently delivered a talk titled “Defense Department-Led Drug Quality Study: Initial Results and Applications for Health Systems.”

The presentation provided a first look at data from a pilot study conducted in partnership with the U.S. Department of Defense, highlighting key insights into drug quality across the supply chain. Light explored how these findings can be applied to strengthen procurement practices, enhance patient safety, and inform broader health system strategies for quality assurance.

The study underscores the value of independent chemical analysis in identifying risks and improving confidence in the medications patients rely on every day.

‍

Valisure President David Light recently delivered a talk titled “Defense Department-Led Drug Quality Study: Initial Results and Applications for Health Systems.”

The presentation provided a first look at data from a pilot study conducted in partnership with the U.S. Department of Defense, highlighting key insights into drug quality across the supply chain. Light explored how these findings can be applied to strengthen procurement practices, enhance patient safety, and inform broader health system strategies for quality assurance.

The study underscores the value of independent chemical analysis in identifying risks and improving confidence in the medications patients rely on every day.

‍